Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Clinically silent myocardial infarctions in the CKD community.

Bansal N.

Nephrol Dial Transplant. 2012 Sep;27(9):3387-91. doi: 10.1093/ndt/gfs171. Epub 2012 Jun 18. No abstract available.

PMID:
22711518
2.

Is albuminuria a myocardial infarction risk equivalent for atherothrombotic events?

Rein P, Saely CH, Vonbank A, Fraunberger P, Drexel H.

Atherosclerosis. 2015 May;240(1):21-5. doi: 10.1016/j.atherosclerosis.2015.02.037. Epub 2015 Feb 24.

PMID:
25746373
3.

Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment.

Najafi I, Shakeri R, Islami F, Malekzadeh F, Salahi R, Yapan-Gharavi M, Hosseini M, Hakemi M, Alatab S, Rahmati A, Broumand B, Nobakht-Haghighi A, Larijani B, Malekzadeh R.

Arch Iran Med. 2012 Feb;15(2):70-5. doi: 012152/AIM.003.

4.

Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.

Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán JF, Zaro MJ, Lozano L, Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB.

J Nephrol. 2013 Jul-Aug;26(4):675-82. doi: 10.5301/jn.5000221. Epub 2012 Oct 15.

PMID:
23100180
5.

Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: a Danish nation-wide cohort study.

Blicher TM, Hommel K, Olesen JB, Torp-Pedersen C, Madsen M, Kamper AL.

Eur Heart J. 2013 Oct;34(37):2916-23. doi: 10.1093/eurheartj/eht220. Epub 2013 Jun 24.

PMID:
23798578
6.

Dietary Salt, Kidney Disease, and Cardiovascular Health.

Powe NR, Bibbins-Domingo K.

JAMA. 2016 May 24-31;315(20):2173-4. doi: 10.1001/jama.2016.5985. No abstract available.

PMID:
27218627
7.
8.

Microalbuminuria in patients with chronic kidney disease at Parirenyatwa Hospital in Zimbabwe.

Chin'ombe N, Msengezi O, Matarira H.

Pan Afr Med J. 2013;14:39. doi: 10.11604/pamj.2013.14.39.1747. Epub 2013 Jan 28. No abstract available.

9.

Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Shah R, Matthews GJ, Shah RY, McLaughlin C, Chen J, Wolman M, Master SR, Chai B, Xie D, Rader DJ, Raj DS, Mehta NN, Budoff M, Fischer MJ, Go AS, Townsend RR, He J, Kusek JW, Feldman HI, Foulkes AS, Reilly MP; CRIC Study Investigators.

Am J Kidney Dis. 2015 Aug;66(2):266-73. doi: 10.1053/j.ajkd.2015.01.021. Epub 2015 Mar 17.

10.

The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, Califf RM, Topol EJ; CREDO Investigators.

Am Heart J. 2008 Apr;155(4):687-93. doi: 10.1016/j.ahj.2007.10.046. Epub 2008 Feb 21.

PMID:
18371477
11.

Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.

Yoda S, Nakanishi K, Tano A, Kasamaki Y, Kunimoto S, Matsumoto N, Sato Y, Hirayama A.

J Cardiol. 2012 Nov;60(5):377-82. doi: 10.1016/j.jjcc.2012.06.011. Epub 2012 Aug 11.

12.

Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry.

Choi JS, Kim CS, Bae EH, Ma SK, Ahn YK, Jeong MH, Kim YJ, Cho MC, Kim CJ, Kim SW; Korea Acute Myocardial Infarction Registry Investigators.

Nephrol Dial Transplant. 2012 Oct;27(10):3868-74. doi: 10.1093/ndt/gfs344. Epub 2012 Aug 9.

PMID:
22879394
13.

[Epidemiology of albuminuria (proteinuria) and its role in clinical trials].

Usui T.

Nihon Jinzo Gakkai Shi. 2015;57(8):1275-80. Japanese. No abstract available.

PMID:
26817152
14.

Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.

Chang FC, Lai TS, Chiang CK, Chen YM, Wu MS, Chu TS, Wu KD, Lin SL.

PLoS One. 2013;8(3):e54668. doi: 10.1371/journal.pone.0054668. Epub 2013 Mar 1.

15.

Relationship between silent brain infarction and chronic kidney disease.

Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Andoh D, Toya Y, Yasuda G, Umemura S.

Nephrol Dial Transplant. 2009 Jan;24(1):201-7. doi: 10.1093/ndt/gfn419. Epub 2008 Aug 12.

16.

Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study.

Salinero-Fort MA, San Andrés-Rebollo FJ, de Burgos-Lunar C, Gómez-Campelo P, Chico-Moraleja RM, López de Andrés A, Jiménez-García R; MADIABETES Group.

PLoS One. 2015 Apr 9;10(4):e0122030. doi: 10.1371/journal.pone.0122030. eCollection 2015.

17.

Should targeting albuminuria be part of a cardiovascular risk reduction paradigm?

Whaley-Connell AT, Kalaitzidis RG.

Cardiol Clin. 2010 Aug;28(3):437-45. doi: 10.1016/j.ccl.2010.04.002.

PMID:
20621248
18.

Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes.

Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y.

Diabet Med. 2010 May;27(5):538-43. doi: 10.1111/j.1464-5491.2010.02922.x.

PMID:
20536949
19.

Interaction of chronic total occlusion and chronic kidney disease in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Bataille Y, Plourde G, Machaalany J, Abdelaal E, Déry JP, Larose E, Déry U, Noël B, Barbeau G, Roy L, Costerousse O, Bertrand OF.

Am J Cardiol. 2013 Jul 15;112(2):194-9. doi: 10.1016/j.amjcard.2013.03.010. Epub 2013 Apr 18.

PMID:
23601580
20.

Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients.

Zalesin KC, McCullough PA.

Adv Chronic Kidney Dis. 2006 Oct;13(4):403-17. Review.

PMID:
17045226

Supplemental Content

Support Center